Riskpilot← Back to searchSign inGet full accessLäkarkonsult Albert Omer AB
ABActiveOrg 5566335179Mitisgatan 3General medical practice activities · NACE 8621Est. 20020 employees
Revenue 2025
SEK 0
EBITDA margin
—
+48% vs 2024
Equity ratio
49.0%
Financial strength
Net profit 2025
SEK -87K
+70% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -122K | +48% |
| Net profit | SEK -87K | +70% |
| Total assets | SEK 2,2M | +1% |
| Equity | SEK 1,1M | -8% |
| Employees | 0 | — |
Legal name
Läkarkonsult Albert Omer AB
Org number
5566335179
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 oktober 2002
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva läkarpraktik, uthyrning av läkare och vårdpersonal, handel med värdepapper, fastighetsförvaltning, samt därmed förenlig verksamhet. Bolaget ska även handla med import och export av metaller samt andra varor och därmed förenlig verksamhet.
Address
Mitisgatan 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 683 | 866 | 280 | 8 | 0 |
| Staff expenses | — | −30 | −28 | −38 | −20 |
| EBITDA | 403 | 656 | 147 | −236 | −122 |
| Depreciation & amort. | −44 | −83 | −7 | −7 | −7 |
| EBIT | 359 | 572 | 140 | −243 | −89 |
| Net financials | −186 | 333 | −38 | −49 | 1 |
| Profit before tax | 233 | 767 | 240 | −292 | −87 |
| Tax | −53 | −85 | −51 | — | — |
| Net profit | 180 | 682 | 189 | −292 | −87 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 249 | 2 428 | 2 352 | 2 145 | 2 158 |
| Equity | 566 | 1 248 | 1 437 | 1 146 | 1 058 |
| Long-term debt | 1 146 | 764 | 730 | 855 | 1 002 |
| Short-term debt | 538 | 279 | 185 | 145 | 98 |
| Total debt | 1 684 | 1 042 | 915 | 999 | 1 100 |
EBITDA margin
-12237300.0%
This company
15.8%
Market median
-77451366% vs market
20212025
Equity ratio
49.0%
This company
38.2%
Market median
+28% vs market
20212025
Return on equity
-8.3%
This company
18.4%
Market median
-145% vs market
20212025
Net profit margin
-8745500.0%
This company
8.1%
Market median
-107969236% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
1.04×
This company
0.62×
Market median
-68% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Läkarkonsult Albert Omer AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aram Bakerson | Deputy Board Member | 0 companies |
| Albert Mark Aras Omer | Board of Directors | 0 companies |